Author:
Rak A. Ya.,Trofimov A. V.,Pigareva N. V.,Simbirtsev A. S.,Ischenko A. M.
Reference18 articles.
1. Mullerian-inhibiting substance;R.L. Cate,1990
2. Chang, H.L., Pieretti-Vanmarcke, R., Nicolaou, F., Li, X., Wei, X., MacLaughlin, D.T., and Donahoe, P.K., Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines, Gynecol. Oncol., 2011, vol. 120, pp. 128–134.
3. Donahoe, P.K., Clarke, T., Teixeira, J., Maheswaran, S., and MacLaughlin, D.T., Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications, Mol. Cell. Endocrinol., 2003, vol. 211, pp. 37–42.
4. Gukasova, N.V. and Severin, S.E., MIS protein: structure, regulation of expression and molecular mechanism of activity, Vopr. Biol. Med. Farmatsevt. Khim., 2005, vol. 4, pp. 3–9.
5. Hoshiya, Y., Gupta, V., Segev, D.L., Hoshiya, M., Carey, J.L., Sasur, L.M., Tran, T.T., Ha, T.U., and Maheswaran, S., Mullerian inhibiting substance induces NFkB signaling in breast and prostate cancer cells, Mol. Cell. Endocrinol., 2003, vol. 211, pp. 43–49.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献